即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.
CAS号 | 1009119-65-6 | 货号 | BCP13025 |
中文名 | 达卡他韦二盐酸盐 | ||
英文名 | Daclatasvir dihydrochloride | ||
中文别名 | |||
英文别名 | Daclatasvir 2HCl;BMS-790052 dihydrochloride;BMS790052 dihydrochloride;BMS 790052 dihydrochloride; EBP883; EBP 883; EBP-883; | ||
SMILES | |||
化学名称 | |||
分子式 | C40H52Cl2N8O6 | 分子量 | 811.8 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | Daclatasvir is NS5A inhibitor and a drug for the treatment of hepatitis C (HCV). It is was developed by Bristol-Myers Squibb and was approved in Europe on 22 August 2014. Daclatasvir inhibits the HCV nonstructural protein NS5A. Recent research suggests that it targets two steps of the viral replication process, enabling rapid decline of HCV RNA. Daclatasvir has been tested in combination regimens with pegylated interferon and ribavirin, as well as with other direct-acting antiviral agents including asunaprevir and sofosbuvir. |
Tags:Daclatasvir dihydrochloride 供应商,Daclatasvir dihydrochloride 购买,Daclatasvir dihydrochloride 生产,Daclatasvir dihydrochloride 批量,Daclatasvir dihydrochloride 供应,Daclatasvir dihydrochloride 订购,Daclatasvir dihydrochloride 采购